Vistagen Therapeutics Inc (VTGN)
4.67
-0.03
(-0.64%)
USD |
NASDAQ |
Apr 26, 09:43
Vistagen Therapeutics Cash from Investing (TTM): -0.5606M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.5606M |
September 30, 2023 | -0.5408M |
June 30, 2023 | -0.5652M |
March 31, 2023 | -0.7403M |
December 31, 2022 | -0.2121M |
September 30, 2022 | -0.1995M |
June 30, 2022 | -0.2256M |
March 31, 2022 | -0.2004M |
December 31, 2021 | -0.2258M |
September 30, 2021 | -0.377M |
June 30, 2021 | -0.4253M |
March 31, 2021 | -0.2754M |
December 31, 2020 | -0.2499M |
September 30, 2020 | -0.0988M |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | -0.0042M |
September 30, 2019 | -0.0042M |
June 30, 2019 | -0.1386M |
March 31, 2019 | -0.174M |
December 31, 2018 | -0.1698M |
September 30, 2018 | -0.1698M |
June 30, 2018 | -0.037M |
March 31, 2018 | -0.0016M |
Date | Value |
---|---|
December 31, 2017 | -0.2308M |
September 30, 2017 | -0.233M |
June 30, 2017 | -0.2371M |
March 31, 2017 | -0.2391M |
December 31, 2016 | -0.0316M |
September 30, 2016 | -0.034M |
June 30, 2016 | -0.0283M |
March 31, 2016 | -0.0263M |
December 31, 2015 | -0.0046M |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | 0.0241M |
June 30, 2014 | 0.00 |
March 31, 2014 | -0.0096M |
December 31, 2013 | -0.0139M |
September 30, 2013 | -0.1691M |
June 30, 2013 | -0.145M |
March 31, 2013 | -0.1354M |
December 31, 2012 | -0.1501M |
September 30, 2012 | -0.0246M |
June 30, 2012 | -0.0324M |
March 31, 2012 | -0.0324M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.7403M
Minimum
Mar 2023
--
Maximum
Mar 2020
-0.2655M
Average
-0.2256M
Median
Jun 2022
Cash from Investing (TTM) Benchmarks
Ardelyx Inc | -131.25M |
Axsome Therapeutics Inc | -0.582M |
Vir Biotechnology Inc | 164.63M |
Immuneering Corp | 7.296M |
NovaBay Pharmaceuticals Inc | -0.019M |